BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. (BCRX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BCRX · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
10
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
BioCryst Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
BCRX insider buying and selling by quarter
BCRX insider selling · BCRX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · BCRX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BCRX executive sell shares · BCRX board member insider trading · BCRX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 29, 2026 | Milne Jill C. Director | Award | 1,262 | $11K | Form 4 |
| May 29, 2026 | Stonehouse Jon P Director | Award | 631 | $6K | Form 4 |
| May 29, 2026 | McKee Amy E Director | Award | 631 | $6K | Form 4 |
| May 29, 2026 | MILANO VINCENT Director | Award | 1,122 | $10K | Form 4 |
| May 29, 2026 | Frank Steven Director | Award | 1,262 | $11K | Form 4 |
| May 18, 2026 | McKee Amy E Director | Sale | 11,180 | $100K | Form 4 |
| May 13, 2026 | Barnes Alane P Chief Legal Officer | Option | 62,500 | $315K | Form 4 |
| May 13, 2026 | Barnes Alane P Chief Legal Officer | Sale | 62,500 | $596K | Form 4 |
| Apr 6, 2026 | Menon Sandeep Chief R&D Officer | Award | 205,150 | — | Form 4 |
| Mar 20, 2026 | HEGGIE THERESA Director | Option | 49,933 | $315K | Form 4 |
| Mar 20, 2026 | HEGGIE THERESA Director | Sale | 49,933 | $505K | Form 4 |
| Mar 16, 2026 | Barnes Alane P Chief Legal Officer | Option | 150,000 | $827K | Form 4 |
| Mar 16, 2026 | Barnes Alane P Chief Legal Officer | Sale | 150,000 | $1.37M⚡ | Form 4 |
| Feb 27, 2026 | Milne Jill C. Director | Award | 528 | $5K | Form 4 |
| Mar 2, 2026 | Stonehouse Jon P Director | Option | 305,995 | $985K | Form 4 |
| Feb 27, 2026 | Stonehouse Jon P Director | Award | 421 | $4K | Form 4 |
| Mar 2, 2026 | Stonehouse Jon P Director | Other | 305,995 | $2.64M⚡ | Form 4 |
| Feb 27, 2026 | MILANO VINCENT Director | Award | 848 | $7K | Form 4 |
| Feb 27, 2026 | Frank Steven Director | Award | 1,285 | $11K | Form 4 |
| Feb 27, 2026 | McKee Amy E Director | Award | 642 | $6K | Form 4 |
| Jan 23, 2026 | Milne Jill C. Director | Award | 12,272 | — | Form 4 |
| Jan 23, 2026 | Milne Jill C. Director | Award | 2,582 | $22K | Form 4 |
| Dec 19, 2025 | Stonehouse Jon P CEO · Director | Other | 61,793 | $458K | Form 4 |
| Dec 19, 2025 | Barnes Alane P Chief Legal Officer | Other | 16,902 | $125K | Form 4 |
| Dec 22, 2025 | Barnes Alane P Chief Legal Officer | Sale | 21,773 | $167K | Form 4 |
Barnes Alane P
Chief Legal Officer
Date
May 13
Shares
62,500
Price
$5.04
Value
$315K
Barnes Alane P
Chief Legal Officer
Date
May 13
Shares
62,500
Price
$9.54
Value
$596K
Barnes Alane P
Chief Legal Officer
Date
Mar 16
Shares
150,000
Price
$5.51
Value
$827K
Barnes Alane P
Chief Legal Officer
Date
Mar 16
Shares
150,000
Price
$9.15
Value
$1.37M ⚡
Barnes Alane P
Chief Legal Officer
Date
Dec 19
Shares
16,902
Price
$7.41
Value
$125K
Barnes Alane P
Chief Legal Officer
Date
Dec 22
Shares
21,773
Price
$7.65
Value
$167K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BCRX insider trading
BCRX insider trades
BioCryst Pharmaceuticals, Inc. (BCRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Barnes Alane P (Chief Legal Officer), Stonehouse Jon P (Director), McKee Amy E (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. BCRX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For BioCryst Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BCRX insider trading · 5 questionsThe insiders of BioCryst Pharmaceuticals, Inc. (BCRX) include executives and directors such as Barnes Alane P (Chief Legal Officer), Stonehouse Jon P (Director), McKee Amy E (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026